Preparation and in vivo evaluation of piroxicam-loaded gelatin microcapsule by spray drying technique.
To develop a piroxicam-loaded gelatin microcapsule with enhanced bioavailability, a gelatin microcapsule encapsulated ethanol and piroxicam has been formulated by using gelatin as a water-soluble polymer shell. The aqueous solubility and bioavailability of piroxicam in piroxicam-loaded microcapsule in rats were then evaluated compared to piroxicam powder. The piroxicam-loaded gelatin microcapsule spherical in shape with smooth surface showed the geometric mean diameter of about 19 microm. It had the piroxicam solubility of about 1.87 mg/ml and the amount of ethanol of about 4.37 microg/mg. Furthermore, it gave significantly higher total plasma concentrations, Cmax and area under the blood concentration-time curve (AUC) of piroxicam in rats than did piroxicam powder, indicating that the drug from gelatin microcapsule could be more orally absorbed in rats. In particular, the AUC of piroxicam in gelatin microcapsule was significantly about 2 fold increased compared to piroxicam powder. This enhanced oral relative bioavailability of piroxicam in gelatin microcapsule was contributed by the marked increase in the absorption rate of piroxicam due to the improved solubility of piroxicam. Thus, the piroxicam-loaded gelatin microcapsule developed using spray-drying technique with gelatin, sodium lauryl sulfate and ethanol would be useful to deliver piroxicam in a pattern that allows fast absorption in the initial phase, leading to better absorption.
Piao
Ming Guan
MG
College of Pharmacy, Yeungnam University, Gyongsan, South Korea.
Yang
Chan-Woo
CW
Li
Dong Xun
DX
Kim
Jong Oh
JO
Jang
Ki-Young
KY
Yoo
Bong Kyu
BK
Kim
Jung Ae
JA
Woo
Jong Soo
JS
Lyoo
Won Seok
WS
Han
Sung Soo
SS
Lee
Yong-Bok
YB
Kim
Dae-Duk
DD
Yong
Chul Soon
CS
Choi
Han Gon
HG
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002214:Capsules; D003890:Desiccation; D004339:Drug Compounding; D000431:Ethanol / Q000032:analysis; D005079:Excipients; D005780:Gelatin; D008297:Male; D008855:Microscopy, Electron, Scanning; D010894:Piroxicam / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012995:Solubility; D012997:Solvents / Q000032:analysis
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002214:Capsules; D005079:Excipients; D012997:Solvents; D010894:Piroxicam; D000431:Ethanol; D005780:Gelatin